Use a three-component comparison
A trade name cannot establish the amount or quality of GHK-Cu, BPC-157 and TB-500 individually. FDA's safety discussion covers those ingredients, including route-specific concerns for GHK-Cu.
Documentation to request
Request a per-component specification and ratio, plus finished-blend compatibility documentation. Do not compare a total blend mass with a single-compound vial.
Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Evidence review before expanding a clinic menu. These references support a review, not a treatment recommendation or supply authorization.